Ingrezza is a prescription medication used in the treatment of tardive dyskinesia, a condition that causes involuntary body movements. Because it is often . . .
Ingrezza is a prescription medication used to manage symptoms of tardive dyskinesia, a neurological movement disorder. Because specialty medications can be expensive, patient . . .
Guide to Accessing Help Through Ingrezza Patient Programs Support is important for patients who are prescribed Ingrezza, a medication commonly used to treat . . .
The Ingrezza Patient Assistance Program is intended to support patients who have been prescribed Ingrezza and need help managing the cost of their . . .
VMAT2 inhibitors are a class of medications used in the treatment of neurological movement disorders such as tardive dyskinesia and Huntington related movement symptoms. These medicines work by . . .
Brain movement disorders refer to a group of neurological conditions that affect the speed, control, quality, and coordination of body movements. These disorders . . .